Vericel's (VCEL) stock price fell sharply by 5.05% during intraday trading on Friday.
The decline followed news that Leerink Partners lowered its price target on the company's shares to $46 from $50. Analyst target price reductions are often interpreted by the market as a sign of diminished growth expectations or valuation concerns, prompting investor selling.